ONCO Onconetix, Inc.
Nasdaq · SEC CIK 1782107 · EDGAR
- Bought, last 12 months
- $152.9K 2 purchases by 1 insiders
- Sold, last 12 months
- $144.5K 2 sales by 1 insiders
- Filings on record
- 43 since 2022-02-24, latest 2026-04-22 14:59
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| HRT FINANCIAL LP | 10% | $152.9K | $144.5K |
Transactions 40
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 14:59 | 2026-04-21 | ONCO | HRT FINANCIAL LP | 10% | S - Sale | $0.69 | -49.7K | 33.6K | -60% | -$34.3K | |
| M | 2026-04-21 15:41 | 2026-04-16+ | ONCO | HRT FINANCIAL LP | 10% | S - Sale | $0.7427 | -148.3K | 83.4K | -64% | -$110.2K |
| 2026-04-21 15:41 | 2026-04-17 | ONCO | HRT FINANCIAL LP | 10% | P - Purchase | $0.73 | +34.6K | 177.8K | +24% | +$25.3K | |
| M | 2026-04-16 14:30 | 2026-04-14+ | ONCO | HRT FINANCIAL LP | 10% | P - Purchase | $0.7645 | +166.9K | 197.1K | +554% | +$127.6K |
| 2025-08-19 | 2025-08-15 | ONCO | Tarsh Simon | Dir | A - Grant | $0.00 | +618 | 658 | +1,545% | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Tarsh Simon | Dir | J - Other | $0.00 | +39 | 40 | +3,900% | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Meier Thomas | Dir | A - Grant | $0.00 | +618 | 657 | +1,585% | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Meier Thomas | Dir | J - Other | $0.00 | +39 | 39 | New | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Oakley Andrew John | Dir | J - Other | $0.00 | +20 | 20 | New | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Oakley Andrew John | Dir | A - Grant | $0.00 | +618 | 638 | +3,090% | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Ramdeen Timothy R. | Dir | A - Grant | $0.00 | +618 | 658 | +1,545% | $0 | |
| 2025-08-19 | 2025-08-15 | ONCO | Ramdeen Timothy R. | Dir | J - Other | $0.00 | +39 | 40 | +3,900% | $0 | |
| D | 2025-07-16 | 2025-07-14 | ONCO | Altos Venture AG | 10% | J - Other | — | +241.5K | 273.2K | +761% | — |
| 2025-03-25 | 2025-03-23 | ONCO | Oakley Andrew John | Dir | A - Grant | $0.00 | +1,709 | 1,709 | New | $0 | |
| 2025-01-22 | 2024-12-20 | ONCO | Schiess Ralph | CSO, Interim CEO | A - Grant | $0.00 | +177.5K | 673.4K | +36% | $0 | |
| 2025-01-22 | 2024-12-20 | ONCO | Bruhlmann Christian | Chief Strategy Off | A - Grant | $0.00 | +177.5K | 611.4K | +41% | $0 | |
| 2024-09-30 | 2024-09-26 | ONCO | SINGH AJIT | Dir | A - Grant | $0.00 | +3,318 | 3,396 | +4,254% | $0 | |
| 2024-09-30 | 2024-09-26 | ONCO | Meier Thomas | Dir | A - Grant | $0.00 | +3,318 | 3,318 | New | $0 | |
| 2024-09-30 | 2024-09-26 | ONCO | SAPIRSTEIN JAMES | Dir | A - Grant | $0.00 | +3,318 | 3,477 | +2,087% | $0 | |
| 2024-09-30 | 2024-09-26 | ONCO | Tarsh Simon | Dir | A - Grant | $0.00 | +3,318 | 3,477 | +2,087% | $0 | |
| 2024-09-30 | 2024-09-26 | ONCO | Ramdeen Timothy R. | Dir | A - Grant | $0.00 | +3,318 | 3,477 | +2,087% | $0 | |
| 2024-09-26 | 2024-09-24 | ONCO | Bruhlmann Christian | Chief Strategy Off | A - Grant | — | +428.0K | 433.9K | +7,254% | — | |
| 2024-09-26 | 2024-09-24 | ONCO | Schiess Ralph | CSO, Interim CEO | A - Grant | — | +489.2K | 495.9K | +7,254% | — | |
| 2024-02-21 | 2024-02-16 | ONCO | SINGH AJIT | Dir | A - Grant | $0.00 | +3,125 | 3,125 | New | $0 | |
| 2023-06-01 | 2023-05-31 | ONCO | Ramdeen Timothy R. | Dir | A - Grant | $0.00 | +6,360 | 6,360 | New | $0 | |
| 2023-06-01 | 2023-05-31 | ONCO | Tarsh Simon | Dir | A - Grant | $0.00 | +6,360 | 6,360 | New | $0 | |
| 2023-06-01 | 2023-05-31 | ONCO | SAPIRSTEIN JAMES | Dir | A - Grant | $0.00 | +6,360 | 6,360 | New | $0 | |
| 2023-06-01 | 2023-05-31 | ONCO | Jeremic Vuk | Dir | A - Grant | $0.00 | +6,360 | 6,360 | New | $0 | |
| 2023-05-11 | 2023-05-09 | ONCO | Hernandez Joseph | CEO, Dir, 10% | A - Grant | — | +150.0K | 2.80M | +6% | — | |
| 2023-05-11 | 2023-05-09 | ONCO | Henderson Erin | Chief Business Off | A - Grant | — | +150.0K | 174.8K | +606% | — | |
| 2023-05-11 | 2023-05-09 | ONCO | Garfield Jon | CFO | A - Grant | — | +100.0K | 100.0K | New | — | |
| 2023-04-12 | 2023-04-10 | ONCO | Cincinnati Cornerstone Investors BWV I, LLC | 10% | J - Other | $0.00 | -1.20M | 1.16M | -51% | $0 | |
| 2022-11-21 | 2022-11-17 | ONCO | Cincinnati Cornerstone Investors BWV I, LLC | 10% | J - Other | $0.00 | -750.0K | 2.36M | -24% | $0 | |
| 2022-08-29 | 2022-08-25 | ONCO | Cincinnati Cornerstone Capital LLC | Other | J - Other | $0.00 | -500.0K | 3.11M | -14% | $0 | |
| D | 2022-08-23 | 2022-08-19 | ONCO | Shaw Allan | Dir | S - Sale | $3.94 | -29.6K | 0 | -100% | -$116.8K |
| D | 2022-08-23 | 2022-08-19 | ONCO | Shaw Allan | Dir | F - Tax | $0.01 | +29.6K | 29.6K | New | +$296.36 |
| D | 2022-08-22 | 2022-08-19 | ONCO | Henderson Erin | Chief Business Off | S - Sale | $3.97 | -4,834 | 24.8K | -16% | -$19.2K |
| DM | 2022-08-22 | 2022-08-18+ | ONCO | Henderson Erin | Chief Business Off | F - Tax | $0.01 | +29.6K | 29.6K | New | +$295.86 |
| M | 2022-08-22 | 2022-08-18+ | ONCO | Hernandez Joseph | CEO, Dir, 10% | S - Sale | $4.81 | -549.6K | 2.65M | -17% | -$2.64M |
| D | 2022-02-24 | 2022-02-23 | ONCO | Cincinnati Cornerstone Investors BWV I, LLC | 10% | C - Cnv Deriv | $0.00 | +3.61M | 3.61M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations